StockData
Castle Biosciences Inc logo

Castle Biosciences Inc (CSTL) stock

CSTLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/303% below fair value
$33.79−0.71 (-2.06%)

Close on Nov 13, 2026Market cap $1.03BP/E –Yield 0.00%

Castle Biosciences statistics

94 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 25, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.03B
$1.68B
Enterprise Value
$764.69M
$2.20B
PS Ratio
2.74
1.53
PB Ratio
2.16
3.46
P/TBV Ratio
2.67
5.80
P/FCF Ratio
260.48
19.86
P/OCF Ratio
25.97
14.68

Enterprise valuationIndustry

EV / Sales
2.03
1.67
EV / FCF
192.96
24.49

Share statisticsIndustry

Shares Change (YoY)
2.15%
2.40%
Shares Change (QoQ)
0.86%
0.33%
Float
30M
34M
Shares Held by Insiders
1.85%
15.4%
Shares Held by Institutions
89.5%
83.6%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
4.59%
-0.86%
Short % of Float
7.03%
6.28%
Short % of Shares Outstanding
6.90%
4.21%
Days to Cover
6.06
4.41

Stock price statisticsIndustry

52-Week High
$44.28
–
52-Week Low
$17.72
–
20-Day Moving Average
$34.49
–
50-Day Moving Average
$34.35
–
200-Day Moving Average
$28.19
–
Average True Range (14)
$1.89
–
Price Change (1 Week)
3.91%
0.23%
Price Change (1 Month)
-0.03%
-0.02%
Price Change (3 Months)
12.8%
2.13%
Price Change (6 Months)
76.6%
17.6%
Price Change (YTD)
-13.1%
5.22%
Price Change (1 Year)
-2.96%
3.75%
Price Change (3 Years)
76.5%
15.2%
Price Change (5 Years)
-34.6%
-14.6%
Average Volume (10 Days)
516,719
–
Average Volume (20 Days)
434,116
–
Average Volume (90 Days)
402,289
–
Relative Volume
0.87
0.70
Relative Strength Index (14)
47.8
46.0
Volatility (1 Year)
53.8%
64.2%
Beta (5 Years)
1.38
0.76

MarginsIndustry

Gross Margin
77.1%
33.3%
Operating Margin
-7.43%
-2.98%
Profit Margin
-6.10%
-2.01%
EBITDA Margin
-3.20%
3.36%
FCF Margin
1.05%
2.98%

Returns on capitalIndustry

Return on Equity (ROE)
-4.87%
4.82%
Return on Assets (ROA)
-4.03%
-3.10%
Return on Invested Capital (ROIC)
-11.1%
4.69%
Return on Capital Employed (ROCE)
-5.48%
0.40%

Financial positionIndustry

Current Ratio
5.28
1.41
Quick Ratio
4.88
0.99
Debt / Equity
0.02
0.68
Debt / FCF
2.54
4.01
Interest Coverage
-51.16
-0.63

GrowthIndustry

Revenue Growth (YoY)
9.78%
9.63%
FCF Growth (YoY)
-84.4%
-6.64%
Revenue Growth (3Y CAGR)
35.9%
11.3%
Revenue Growth (5Y CAGR)
40.6%
12.6%

EfficiencyIndustry

Asset Turnover
0.66
0.81
Inventory Turnover
9.09
10.99
Revenue Per Employee
$427.10K
$235.26K
Profits Per Employee
-$26.06K
-$5.12K
Employee Count
883
910
WACC
11.9%
8.40%

Income statement (TTM)Industry

Revenue
$377.13M
$638.13M
Gross Profit
$290.66M
$196.31M
Operating Income
-$28.04M
-$675.66K
Net Income
-$23.01M
-$1.48M
EBITDA
-$12.08M
$1.17M
EPS (Diluted)
-$0.77
-$0.02

Balance sheetIndustry

Total Debt
$10.08M
$258.06M
Net Cash (Debt)
$267.58M
$203.66K
Net Cash Per Share
$8.76
$0.00
Equity (Book Value)
$478.44M
$235.60M
Book Value Per Share
$15.66
$3.91
Tangible Book Value
$386.94M
$1.59M
Working Capital
$289.25M
$30.06M

Cash flow (TTM)Industry

Operating Cash Flow
$39.74M
$25.90M
Capital Expenditures
-$35.78M
-$15.83M
Free Cash Flow
$3.96M
$18.83M
FCF Per Share
$0.13
$0.36

Dividends and yieldsIndustry

Earnings Yield
-2.23%
0.19%
FCF Yield
0.38%
2.55%
Dividend Yield
0.00%
0.54%
Shareholder Yield
0.00%
1.58%
Dividend Per Share
$0.00
$1.30
Years of Dividend Growth
0
4

Taxes and interestIndustry

Interest Expense
$548.00K
$7.37M
Income Tax
$395.00K
$564.50K

Scores and fair valueIndustry

Altman Z-Score
6.63
2.24
Piotroski F-Score
4
5
Beneish M-Score
-3.46
-2.76

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodCSTLS&P 500DifferenceCSTL per yearS&P 500 per year
1 month+2.8%-3.0%+5.8 pts
3 months+10.6%-2.8%+13.4 pts
Year to date-13.1%+11.5%−24.6 pts
1 year-1.0%+13.5%−14.4 pts
3 years+90.7%+77.7%+13.0 pts+24.0%+21.1%
5 years-34.6%+72.6%−107.2 pts-8.1%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M CSTL shares were sold short on Oct 30, 2026, up 4.6% from the previous report, or 7.03% of the shares available to trade. At recent volumes it would take 6.1 days to buy them back. Over the last 20 sessions, 48.4% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,109,010+4.6%347,9296.1
Oct 15, 20262,016,505+0.8%337,0536.0
Sep 30, 20261,999,726+5.3%419,6334.8
Sep 15, 20261,899,369-3.9%257,9377.4
Aug 31, 20261,976,754+12.7%391,4375.0
Aug 14, 20261,753,605+12.3%477,0953.7
Jul 31, 20261,561,988+9.9%491,9793.2
Jul 15, 20261,421,793-4.7%251,0975.7
Jun 30, 20261,491,750+0.5%469,0053.2
Jun 15, 20261,485,061+0.0%284,2225.2
May 29, 20261,484,771+4.9%393,0313.8
May 15, 20261,415,745-0.9%633,8712.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?